Fatemeh Ayoobi

Dr. Fatemeh Ayoobi

orcid
Occupational Safety and Health Research Center, NICICO, Worl

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2021 in BMC Urology
Verified
Journal Article
Open access
PDF file
PKParvin Khalili
Parvin Khalili
ZJZahra Jamali
Zahra Jamali
TSTabandeh Sadeghi
Tabandeh Sadeghi
AEAli Esmaeili-Nadimi
Ali Esmaeili-Nadimi
MMMaryam Mohamadi
Maryam Mohamadi
ANAlireza Nazari
Alireza Nazari
Background: The prevalence of kidney stones in the world is increasing and environmental factors seem to play a major role in this issue. The aim of the present study was to investigate the prevalence of risk factors of kidney stones in the adult population of Rafsanjan city based on the data of the Rafsanjan Cohort Study (RCS). Methods: In the baseline phase of this study, 10,000 people aged 35 to 70 years are enrolled in the RCS, as one of the prospective epidemiological research studies in Iran. From this population, 9932 participants completed related demographic questionnaires as well as reported a history of diabetes mellitus, kidney stone, and hypertension diseases. The obtained data were analyzed using univariable and multivariable logistics regression. Results: According to the obtained results, 46.54% of the studied population were male and 53.46% were female. The mean age of the participants was 49.94 ± 9.56 years. 2392 people accounting for 24.08% of the population had kidney stones. After adjustment of the variables, six variables of gender, WSI, no consumption of purified water, BMI, and history of hypertension and diabetes were found to be significant related factors of kidney stone disease. Conclusions: Gender, hypertension, obesity, diabetes, and personal habits like alcohol consumption, opium use and, cigarette smoking are effective in the development of kidney stones. So, by identifying the susceptible patients and teaching them, the burden of the disease on society and the individual can be reduced. The results of this study are helpful to health care providers for preventive planning for kidney stone disease.

1 January 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
GBGholamreza Bazmandegan
Gholamreza Bazmandegan
MBMohammad Taher Boroushaki
Mohammad Taher Boroushaki
ASAli Shamsizadeh
Ali Shamsizadeh
FAFatemeh Ayoobi
Fatemeh Ayoobi
EHElham Hakimizadeh
Elham Hakimizadeh
MAMohammad Allahtavakoli
Mohammad Allahtavakoli

12 July 2017 in Neurological Research
Verified
Journal Article
Closed access
ZHZahra Hadadianpour
Zahra Hadadianpour
FFFarangis Fatehi
Farangis Fatehi
FAFatemeh Ayoobi
Fatemeh Ayoobi
AKAyat Kaeidi
Ayat Kaeidi
ASAli Shamsizadeh
Ali Shamsizadeh
IFIman Fatemi
Iman Fatemi
Objective: The aim of this study was to evaluate the effect of orexin-A (OX-A) and the orexin-1 receptor antagonist SB-334867 (SB) on motor and cognitive functions in a rat model of Parkinson’s disease. Methods: Parkinson was induced by intracerebroventricular (i.c.v) injection of 6- hydroxydopamine (6-OHDA) (200 μg/rat). 72 h later, the treatment was initiated by i.c.v administration of SB (30 nmol/rat) and/or OX-A (0.3 nmol/rat) for 10 days. Motor functions were monitored using rotarod and hanging tests. Cognitive function was assessed by passive avoidance test (Shuttle box). Results: OX-A administration in 6-OHDA treated rats remarkably increased the time which animals run on rod (in rotarod test) and also the latency to fall (in hanging test) (P < 0.01 and P < 0.001, respectively). Conversely, administration of SB in 6-OHDA-treated rats decreased the mentioned indices (P < 0.05 for latency to fall). Administration of agonist and/or antagonist of orexin-1 receptors had no significant effect on 6-OHDA induced cognitive impairment in rats. Conclusion: Results of this study suggest that the orexinergic system might be involved in sensory-motor deficits of Parkinson’s disease.

1 February 2019 in Life Sciences
Verified
Journal Article
Closed access
MMMerat Mahmoodi
Merat Mahmoodi
HAHoushang Amiri
Houshang Amiri
FAFatemeh Ayoobi
Fatemeh Ayoobi
MRMehdi Rahmani
Mehdi Rahmani
ZTZahra Taghipour
Zahra Taghipour
MSMojtaba Sankian
Mojtaba Sankian

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MMMerat Mahmoodi
Merat Mahmoodi
FAFatemeh Ayoobi
Fatemeh Ayoobi
AAAzita Aghaei
Azita Aghaei
MRMehdi Rahmani
Mehdi Rahmani
ZTZahra Taghipour
Zahra Taghipour
MSMojtaba Sankian
Mojtaba Sankian
The imbalance between pro and anti-inflammatory cytokines plays an important role in the pathogenesis of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Thymus vulgaris (thyme) as a traditional medicinal plant has been reported to exert antimicrobial, antioxidant, and anti-inflammatory effects. Therefore, this study evaluated the modulatory effects of Thymus vulgaris on the clinical symptoms, histopathological scores, and the production of some anti-inflammatory (TGF-β, IL-4, and IL-10) and pro-inflammatory (IFN-γ, IL-6 and IL-17) cytokines in EAE model. EAE was induced by MOG35-55 peptide and mice were treated intra-peritoneally (i.p) with phosphate buffered saline (PBS) in the control group or thyme extract (50 or 100 mg/kg of body weight, every other day) in thyme-treated EAE groups, from day 0 to +21 of post MOG immunization. Mice were sacrificed at day 22, and splenocytes were isolated and re-stimulated in vitro with MOG in order to measure the cytokine production and proliferation of re-stimulated cells by enzyme linked immunosorbent assay (ELISA) method and WST-1 reagent, respectively. The clinical symptoms and histopathological scores of the CNS were lower in thyme-treated than EAE control group. Furthermore, the production of IFN-γ and IL-6 by splenocytes was lower in thyme-treated EAE than in the control group. The production of IL-10 and TGF-β increased in mice treated with thyme extract compared to the control group. In this study, we showed for the first time that the immunomodulatory effects of Thymus vulgaris in EAE model. Thus, the possible therapeutic potential of thyme for treatment of MS could be considered in future research.

1 June 2017
Verified
Journal Article
Open access
PDF file
FAFatemeh Ayoobi
Fatemeh Ayoobi
ASAli Shamsizadeh
Ali Shamsizadeh
IFIman Fatemi
Iman Fatemi
AVAlireza Vakilian
Alireza Vakilian
MAMohammad Allahtavakoli
Mohammad Allahtavakoli
AMAmir Moghadam-Ahmadi
Amir Moghadam-Ahmadi
The Achillea millefolium L. (Yarrow) is a common herb which is widely being used, worldwide. Achillea is being used for treatment of many disorders since centuries. It is considered safe for supplemental use and flavonoids such as kaempferol, luteolin and apigenin are of main constituents present in Achillea. Most of both antioxidant and anti-inflammatory properties of this herb have been attributed to its flavonoid content. Oxidative and inflammatory processes play important roles in pathogenesis of neurodegenerative diseases. Present review was aimed to review the latest literature evidences regarding application of Achillea and/or its three main flavonoid constituents on epilepsy, Alzheimer's disease, multiple sclerosis, Parkinson's disease and stroke.